We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess? Anyway, now GILD highly tightened to SNP and thus electional uncertainty.
NASDAQ:GILD Based on technical analysis, the idea is to go long only if the bottom support level of 60 USD will not be broken. Target prices are: 1. 68USD 2. 80 USD
If break below $60, bull have to be caution.
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure...
Hearing chatter down the grape vine about Remdesivir again, watch for the bounce back-up on GILD. This was just trading in the $80 dollar range so keep an eye out for that move on the news.
GILEAD SCIENCES, daily timeframe: Support zone + Side of Bollinger Bands + Hammer
📍 The effect of Remdesivir... The power to unlock the all time highs via Covid is systematically, within reach rather fast, due to the nature of drug prices which are inelastic. The effect of Gilead being treated as utility is heightened by DT putting the big orders in. Compare the following two diagrams: Phase III trials & Chinese red carpet ...
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the...
Technical Analysis: HOLD BEFORE GOING LONG -Wait that the resistance level will be broken before buying. Fundamental Information: Gilead Was Approached by AstraZeneca About Potential Merger
Just Hold for now. It is too risky invest in this stock right now
U.S. FDA approved Gilead Sciences Inc.’s experimental antiviral drug, remdesivir, for use as it’s showing good signs of helping hospitalised patients recover more quickly from Corona Virus. From a Trend Analysis perspective - price action has been very choppy with lots of buying and selling in an almost Up-trending consolidation. We expect Gilead to push...
NYT: FDA PERMISSION FOR GILEAD AGAINST COVID-19 IN EMERGENCIES MAY BE ANNOUNCED ALREADY TODAY Buy now Sell levels on the chart Profit +250-400 % Wish you luck !